1 bowel in nine, liver-bowel in five, and one
multivisceral.
2 small bowel/liver, 5.7% heart/lung, and 3.3%
multivisceral.
3 estine alone, 75 liver and intestine, and 25
multivisceral.
4 9, lung: 1, bone marrow: 1, liver-kidney: 1,
multivisceral:
1).
5 intestine (24%), liver-intestine (62%), and
multivisceral (
14%).
6 aft rejection, but their role in small bowel/
multivisceral allograft remains unclear.
7 the eight simultaneous LTx/KTx was part of a
multivisceral allograft.
8 of organ-specific susceptibility to CR among
multivisceral allografts with a tendency for the pancrea
9 f organ-specific susceptibility to ACR among
multivisceral allografts with the small intestinal allog
10 tacrolimus immunosuppression for intestinal,
multivisceral,
and liver transplantation.
11 ents received 24 grafts: 14 intestinal, nine
multivisceral,
and one liver-intestinal graft.
12 gans included isolated small bowel, modified
multivisceral (
bowel, pancreas, and stomach) and multivi
13 ivisceral (bowel, pancreas, and stomach) and
multivisceral (
bowel, pancreas, stomach, and liver).
14 Multivisceral ex vivo surgery applying techniques of dec
15 We performed three cases of
multivisceral ex vivo surgery involving temporary remova
16 Patients with a
multivisceral graft experienced less episodes of severe
17 cessful procurement and transplantation of a
multivisceral graft from a pediatric donor with polysple
18 ormed transplants of the spleen as part of a
multivisceral graft in an attempt to decrease both the r
19 The
multivisceral graft recipients were more likely to devel
20 Younger children,
multivisceral graft recipients, and particularly those w
21 Our results show that the
multivisceral graft seems to facilitate engraftment of t
22 llograft spleen can be transplanted within a
multivisceral graft without significantly increasing the
23 The inclusion of the spleen in the
multivisceral grafts tended to be at an increased risk o
24 We reviewed our experience with
multivisceral grafts that included the entire pancreas.
25 e were no episodes of pancreatitis in the 44
multivisceral grafts which included a transplant pancrea
26 an era of severe organ shortage of pediatric
multivisceral grafts, a valuable organ offer should not
27 ino children with gastroschisis who received
multivisceral grafts.
28 lated bowel in two, liver-bowel in four, and
multivisceral in nine (four with kidney).
29 and worse overall outcomes after intestinal/
multivisceral (
MV) transplantation.
30 receiving liver (OLTX), intestinal (ITX) or
multivisceral (
MVT) transplants.
31 tine (n = 28), liver and intestine (n = 27),
multivisceral (
n = 61), and multivisceral without the li
32 he 12 resuscitated grafts, two were used for
multivisceral,
one for a modified multivisceral, seven f
33 5 centimeters (OR: 0.40, CI: 0.23-0.67), and
multivisceral procedures (OR: 0.39, CI: 0.26-0.59).
34 All primary
multivisceral recipients who received a donor spleen (N
35 In 79 intestine/
multivisceral recipients, sera were prospectively screen
36 Recipients of
multivisceral,
redo, and lobar lung transplants and thos
37 Patients with RMP had much higher rates of
multivisceral resection (40.4% vs 12.8%; relative risk,
38 m, P = 0.007) and were more often treated by
multivisceral resection (LND: 47.8% vs no-LND: 18.1%; P
39 ollected and the feasibility and efficacy of
multivisceral resection for locally advanced clinical T4
40 orbidity and mortality rates, and an en bloc
multivisceral resection should be performed in patients
41 iate analysis adjusted for age, tumor stage,
multivisceral resection, adjuvant treatment, and lymph n
42 The role of
multivisceral resection, in the setting of locally advan
43 margin leads to high rates of conversion and
multivisceral resection.
44 e used for multivisceral, one for a modified
multivisceral,
seven for liver-intestine, and two for is
45 In this modified
multivisceral technique, the native spleen and pancreas
46 mporaneous parallel development of liver and
multivisceral transplant models (Theme II).
47 lymphoma involving the intestinal graft of a
multivisceral transplant patient.
48 homa affecting the intestinal allograft of a
multivisceral transplant patient.
49 The Indiana University Intestinal and
Multivisceral Transplant program experienced significant
50 We report an adult
multivisceral transplant recipient who experienced recur
51 s were taken from 4 isolated intestine and 3
multivisceral transplant recipients at the time of any o
52 plication of this technique in two pediatric
multivisceral transplant recipients--one to buttress a l
53 ed from 111 consecutive pediatric intestinal/
multivisceral transplant recipients: 2155 were obtained
54 s a 7-year-old girl who underwent at age 5 a
multivisceral transplant secondary to short gut syndrome
55 A
multivisceral transplant was performed.
56 Multivisceral transplant was protective with respect to
57 tion with the stronger predictor "receipt of
multivisceral transplant" was controlled (P=0.23).
58 in the long term after pediatric intestinal/
multivisceral transplant.
59 Liver-sparing "modified"
multivisceral transplantation (MMVTx) has recently been
60 of isolated intestinal transplantation (IIT)/
multivisceral transplantation (MVT) are among those at t
61 Multivisceral transplantation (MVtx) involves simultaneo
62 t (SOT) group (n = 15; 12 ITX and 3 modified
multivisceral transplantation [MMVTX]) and the SOT-AWTX
63 This new modification of
multivisceral transplantation allows pancreaticosplenic
64 ential complications after isolated bowel or
multivisceral transplantation and long-term graft surviv
65 Small intestinal allografts in
multivisceral transplantation are felt to be more suscep
66 The patient underwent a
multivisceral transplantation as a life-saving procedure
67 ysis of 98 consecutive patients who received
multivisceral transplantation at our institution.
68 Multivisceral transplantation can be valuable for the tr
69 Intestinal and
multivisceral transplantation could be considered in pat
70 Multivisceral transplantation cured the patient's underl
71 ld woman with short bowel syndrome underwent
multivisceral transplantation due to total parenteral nu
72 only one report in the literature mentioning
multivisceral transplantation for a patient with life-th
73 his is the first report in the literature of
multivisceral transplantation for MMIHS.
74 A common requirement of
multivisceral transplantation has been removal of the na
75 Multivisceral transplantation has recently evolved to be
76 Our case reports suggest that
multivisceral transplantation is a valuable therapeutic
77 urgery applying techniques of deceased donor
multivisceral transplantation is feasible in achieving l
78 Multivisceral transplantation is now an effective treatm
79 and contour in children undergoing bowel and
multivisceral transplantation is often challenging due t
80 this study was to summarize the evolution of
multivisceral transplantation over a decade of experienc
81 One
multivisceral transplantation patient underwent isolated
82 In this cohort of small bowel/
multivisceral transplantation patients, there was a high
83 3 isolated intestinal transplantation and 9
multivisceral transplantation patients.
84 We believe that
multivisceral transplantation should be considered as a
85 Multivisceral transplantation should be considered as a
86 ience with three patients with MMIHS in whom
multivisceral transplantation was performed.
87 Early experience with intestinal and
multivisceral transplantation was plagued with high risk
88 In 2001, indications for
multivisceral transplantation were expanded, and inducti
89 designed a new approach and have performed a
multivisceral transplantation with splenopancreatic pres
90 l hemitransposition, portal arterialization,
multivisceral transplantation) are associated with subop
91 Outcomes evaluated included need for liver/
multivisceral transplantation, mortality, and the clinic
92 Three patients with MMIHS underwent
multivisceral transplantation.
93 patients continue to be considered for liver/
multivisceral transplantation.
94 with worse clinical outcomes after intestine/
multivisceral transplantation.
95 sirolimus-associated PRES in the setting of
multivisceral transplantation.
96 osure in both adults and pediatric liver and
multivisceral transplantation.
97 15/11) obtained from recipients after SBT or
multivisceral transplantation.
98 hirty-seven patients underwent intestinal or
multivisceral transplantation.
99 s now a common practice after intestinal and
multivisceral transplantation.
100 s (Tac) immunosuppression for intestinal and
multivisceral transplantation.
101 unresponsive to all therapies, we performed
multivisceral transplantation.
102 . 25%, combined liver and SBTx=100% vs. 30%,
multivisceral transplantation=25% vs. 50%.
103 Multivisceral transplanted patients experienced less epi
104 However, in a subset analysis of
multivisceral transplanted patients since 2003, a favora
105 introduction of tacrolimus, small-bowel and
multivisceral transplantion has increased to 100-200/yea
106 isolated intestinal transplants and modified
multivisceral transplants (7 of 10, 70%).
107 Forty-six intestinal and
multivisceral transplants (MVtx) were performed between
108 In multivariable analysis, use of a
multivisceral (
with or without liver) transplant (P = 0.
109 estine (n = 27), multivisceral (n = 61), and
multivisceral without the liver (n = 7).